Scott A. Irwin, MD, PhD; FACLP, FAPA, FAPOS - Ketamine in the Medically Ill: From Mechanism to Clinical Translational Delivery, 12-17-2021
Scott A. Irwin, MD, PhD, is a board-certified psychiatrist at Cedars-Sinai Medical Center. He strives to improve outcomes for those with cancer or other progressive, potentially life-limiting illnesses, and their families, through leading-edge clinical services, ongoing research, and program development, improvement and implementation. Dr. Irwin has received research funding from the NIMH, the National Palliative Care Research Center, the Archstone Foundation and the John A. Hartford Center of Excellence in Geriatric Psychiatry at UC San Diego. He is the author/co-author of over 100 articles, chapters and abstracts, is frequently quoted in the media, and has been recognized at many levels for his innovative research, teaching and clinical endeavors. Dr. Irwin earned his Bachelor of Science in psychobiology from the University of California, Los Angeles, and his PhD in neuroscience at the University of Illinois, Urbana-Champaign. In 2006, he successfully completed his psychiatry residency at UC San Diego as chief resident of Outpatient Psychiatric Services, as well as a two-year elective in hospice and palliative care at San Diego Hospice and The Institute for Palliative Medicine. He is a diplomate of the American Board of Psychiatry and Neurology, with subspecialty certification in psychosomatic medicine. In 2014 he was named a fellow of the Academy of Psychosomatic Medicine, and in 2015, he was named a fellow of the American Psychiatric Association.